Psychedelics Today
(Brighton, UK) joins Joe Moore for a grounded conversation on the boom in functional mushrooms and why the category may be moving too quickly. As the founder of , Oli works with consumers and brands to demystify functional mushrooms, with a focus on education, traceability, and realistic expectations. The conversation begins with a critique of wellness hype cycles. Oli explains how consumer desperation for help with anxiety, sleep, stress, and cognition can create an opening for a rapid wave of products that are not always grounded in careful sourcing or clear science. Using as a case...
info_outlinePsychedelics Today
In this live episode, joins to discuss . She explains why many Indigenous initiatory systems begin with consultation and careful assessment of the person, often using divination and lineage-based diagnostic methods before anyone enters ceremony. Eastman contrasts that with modern frameworks that can move fast, rely on short trainings, or treat the medicine as a stand-alone intervention. Early Themes: Ritual, Preparation, and the Loss of Container Eastman describes her background, including ancestral roots in Mexico and her later work at Crossroads Ibogaine in Mexico, where she supported...
info_outlinePsychedelics Today
Logan Davidson joins the show to talk about the fast-moving world of Ibogaine in American and why state-based leadership is shaping the future of psychedelic reform. Davidson is the executive director of , the legislative director at , and a key strategist behind Texas’ landmark interest in ibogaine research. He also advises for . His work sits at the intersection of science, policy, and lived experience, and this conversation offers a clear look into what is happening right now. Early Themes: The Rise of State Advocacy Davidson explains how he entered politics at nineteen and how his...
info_outlinePsychedelics Today
In this episode, joins Kyle Buller to explore truth, healing, and psychedelic-assisted psychotherapy through the lens of his new book, . A clinical psychologist, ordained Zen Buddhist monk, retreat leader, and fellow at the Institute of Noetic Sciences, he blends Buddhist psychology, trauma work, and consciousness studies. The discussion focuses on how people discover and live their truth, and why that truth becomes the core medicine in healing. Early in the Podcast with Michael Sapiro describes how years of clinical work and retreat facilitation shaped his understanding of healing....
info_outlinePsychedelics Today
sits at the center of this wide ranging conversation between Psychedelics Today co-founders Joe Moore and Kyle Buller. Drawing from decades of personal practice and assorted types of breathwork facilitation, they explore how breathwork methods from the Grof lineage including can prepare people for psychedelic work, support difficult journeys, and deepen integration over time. Kyle shares how his near death experience, somatic training, and breathwork facilitation shaped this new course on breathwork foundations, while Joe reflects on how reading Dr Stanislav Grof and years of experience in...
info_outlinePsychedelics Today
Alexander joins Psychedelics Today to explore how psychedelics, culture, and power shape each other. A writer, facilitator, and co founder of the conference and the media platform , he has spent years thinking about how psychedelic experiences ripple into politics, economics, conflict, and community. In this episode, he and Joe trace the path from early internet forums to today’s psychedelic renaissance, and ask what it would mean to bring a truly psychedelic perspective into our institutions. Beiner is less interested in psychedelics as a niche medical tool and more interested in how they...
info_outlinePsychedelics Today
Overview Evelyn Eddy Shoop PMHNP-BC joins Psychedelics Today to share her journey from Division I athlete to psychiatric mental health nurse practitioner and psilocybin research participant. In this conversation, she explains how sports injuries, OCD, and intensive treatment led her into psychiatry and eventually into a psilocybin clinical trial at Yale. Her story weaves together lived experience, clinical training, and a call for more humane systems of care and better qualitative data in psychedelic science. Early Themes: Injury, OCD, and Choosing Psychiatry Early in the episode, Evelyn...
info_outlinePsychedelics Today
In this episode, Joe Moore sits down with Dr. Jason Konner, a longtime oncologist who recently left his full-time clinical role at to devote himself to the emerging intersection of cancer care and psychedelics. Dr Konner shares how, after more than two decades treating people, he hit a wall. The accumulated grief, constant exposure to death, and intensity of oncology left him deeply , though he didn’t have that language for it at the time. A chance moment in a yoga class, overhearing someone say “ retreat” just before he was scheduled for hernia surgery, became the turning point....
info_outlinePsychedelics Today
Clinical psychologist Dr. Genesee Herzberg joins Kyle to reflect on two decades in trauma work and 15 years inside the psychedelic ecosystem—from early MAPS conferences to running Sage Integrative Health. She traces how personal psychedelic experiences set her on a path of service, research at CIIS on MDMA-assisted therapy, and hands-on roles with MAPS: Zendo Project harm reduction, adherence rating, and ultimately serving as an MDMA therapist in clinical trials. Today she leads Sage, an integrative clinic (psychotherapy, psychiatry, bodywork, acupuncture, and functional nutrition) focused...
info_outlinePsychedelics Today
Clinical psychologist joins to share insights from her decade of work with and her evolving focus on community-based integration. As the former Clinical Lead for , Dr. Watts witnessed how psychedelic experiences can foster profound feelings of — to self, others, and nature — yet also how that connection can fade without ongoing support. In this conversation, she reflects on what years of research have taught her about connectedness as both a healing mechanism and a human need. She explores how can transform fleeting psychedelic breakthroughs into lasting change, and why community is...
info_outlineIn today's Solidarity Fridays episode, Joe and Kyle sit down and talk about recent items in the news, and dive deep into analyzing 2 articles that are very critical of MAPS' involvement with the police, military, and government.
They first discuss Canada-based nonprofit TheraPsil's recent win of four people with incurable cancer being granted the ability to use psilocybin for end-of-life therapy, and how this framework could be copied and used in the US through the Right-to-try act, signed into law in 2018.
They then discuss Dimitri Mugianis's recent article in Salon, which highlighted the long history of psychedelics being used in negative ways, from Vikings presumably using some sort of mushroom to get to a pillaging, "Berserker warrior" mindstate, to the 11th century Nizari Isma'ili State, which reportedly used hashish as a tool for motivation and control, to MKUltra and experiments on Whitey Bulger, to the most recent death of Elijah McLain from a large forced injection of ketamine. And they discuss David Nickles's article in Psymposia, which poses that since MAPS is working to provide treatment to police and soldiers with PTSD, they are essentially in bed with the enemy, and only promoting organizations that create more violence, division, trauma, and PTSD, while treating the perpetrators instead of the victims.
Both articles are critical of MAPS but neglect to see the importance of diplomacy and working to see eye to eye with people in disagreement for the greater good- that yes, these tools can be used against people, but can also be used by people, with immense benefits. Joe reads a comment sent in by listener Danny McCraken, pointing out that "as the saying goes, ‘only Siths deal in absolutes.’" This leads to more discussion: when and how should ketamine be used for submission? Why do healthy, trained cops need to even get to that point? How much of this is just governments trying to make the costs of war cheaper? Why don't more people see things from all sides?
Lastly, they remind us that on September 17th, 2 new rounds of (now CE-approved) Navigating Psychedelics will be starting up, and there is a new class for sale developed with Johanna Hilla-Maria Sopanen called "Imagination as Revelation," which focuses on Jungian psychology and how it can be applied to understanding psychedelic experience.
Notable quotes
“I remember when we chatted with Dr. Katherine MacLean way, way back when we first got it rolling. Something that she said- ‘it’s almost like a birthright for us to try to prepare for death. And do we have to wait to have some sort of end-of-life illness, or can we start trying to prepare a little bit earlier?’ Just really awesome to see that these 4 patients will be able to have an experience and maybe discover things about themselves during their last time here. So congrats TheraPsil for making that work for these folks.” -Kyle
“From the anarchist perspective, this just helps governments, which are typically organizations that have monopolies on power (what anarchists are against, primarily). So any kind of government that’s using tools against people is bad, and these are tools that are being used against people. They’re also being used for people. It’s this weird dichotomy of: these things have such huge healing benefit for so many different types of people, and they can also be used to support things that are against people, like any tool. Like a knife or a gun- it can be used to save a life or take a life.” -Joe
“Is this what we want? Last episode, we talked a lot about decriminalization vs. legalization, and we didn’t really talk about how that contrasts with medicalization. Do we really want these powerful people in groups telling you when you can and cannot take these things? I think the answer is no. We don’t want that. We want autonomy. We want cognitive liberty. We want to not go to jail for this stuff. We want safe access.” -Joe
“Essentially, the critique is that MAPS is supporting cops (PTSD) and soldiers (PTSD), and as a result, MAPS is supporting violent organizations that are causing more PTSD, and treating the perpetrators vs. treating the victims. I understand why they would write this article, but I think it’s not done in good taste. I think it’s not necessarily aware of the broader implications of these things coming to market and being prescribable and healing a lot of people. But it is helpful in that it says, ‘Look, cops are doing bad stuff. Military has done bad stuff. Should we be supporting it?’ ...How do we balance those two things? ...I think MAPS is almost at the finish line, so I’m going to cheerlead for MAPS to finish [and] cross the line with MDMA, even though they’re kind of pandering to the militarized people who have a monopoly on violence, both inside and outside of the country.” -Joe
Links
4 Palliative Canadians approved for end of life psilocybin therapy
BP will slash oil production by 40% and pour billions into green energy
Salon: How psychedelic drugs are used as a tool of state violence
Support the show
- Patreon
- Leave us a review on Facebook or iTunes
- Share us with your friends
- Join our Facebook group - Psychedelics Today group – Find the others and create community.



